Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases
- 1 January 2026
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 10 (1) , e2500748
Abstract
PURPOSE: Early-onset endometrial cancer (eoEC) is increasing, and germline drivers may be enriched in younger patients. We sought to define germline pathogenic variants (gPVs) in those with EC by age. METHODS: We identified patients with EC who underwent clinical tumor-normal sequencing from December 2014 to June 2021 and collected clinical variables. Logistic regression models evaluated associations between age at EC diagnosis and presence of gPV, biallelic inactivation, and Lynch Syndrome (LS). Age categories were defined as early-onset (eoEC, EC < 50 years) and late-onset (EC ≥ 70 years) and were compared with those diagnosed ages 50-69 years. RESULTS: Among 1,625 patients with EC, the median age at diagnosis was 63 (range, 24-96) years. We observed gPV in 28 (16%) of 170 patients with eoEC, 152 (14%) of 1,066 patients diagnosed age 50-69 years, and 36 (9%) of 389 patients with late-onset EC ( P = .016). LS was enriched in eoEC, with 6.5% of patients diagnosed age <50 years having LS. In multivariable models compared with those with EC diagnosed age 50-69 years, eoEC was more likely to exhibit biallelic inactivation (odds ratio, 3.34 [95% CI, 1.44 to 7.35]) and be associated with LS (hazard ratio [HR], 3.49 [95% CI, 1.63 to 7.01]). Among early-onset EC, 14 (50%) of 28 gPV were high penetrance and 14 (50%) of 28 exhibited biallelic inactivation. However, heterogeneity was observed, and rates of gPV were 8.9% and 19%, biallelic inactivation was 0% and 11%, and LS was 2.2% and 8% in those diagnosed age <40 years and 40-49 years, respectively. CONCLUSION: Rates of gPV, biallelic inactivation, and LS differ across age groups for EC, with high-penetrant genes driving tumorigenesis enriched in younger patients. However, very-early-onset EC may have different drivers and necessitates more research.Keywords
This publication has 44 references indexed in Scilit:
- Uterine Cancer Incidence and Mortality — United States, 1999–2016MMWR. Morbidity and Mortality Weekly Report, 2018
- Risk factors for endometrial cancer: An umbrella review of the literatureInternational Journal of Cancer, 2018
- Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic CancerJAMA, 2018
- Racial disparities in young women with endometrial cancerGynecologic Oncology, 2018
- Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline TestingJAMA, 2017
- Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and TreatmentJournal of Clinical Oncology, 2016
- Counselling framework for moderate-penetrance cancer-susceptibility mutationsNature Reviews Clinical Oncology, 2016
- Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAJAMA Oncology, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Prospective Determination of Prevalence of Lynch Syndrome in Young Women With Endometrial CancerJournal of Clinical Oncology, 2007